Kleanthis G. Xanthopoulos

Filings by Kleanthis G. Xanthopoulos span 2 companies, the busiest being Seelos Therapeutics, Inc. and Zosano Pharma Corp. Over a trading history stretching from 5 April 2016 to 10 June 2021, the count stands at 7 filings.

Purchases make up the whole of the open-market record (1 purchase, €19k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants.

On 14 June 2021 came the latest disclosure, a share grant in Zosano Pharma Corp. The clock since the last published purchase (22 August 2016) now reads 3,714 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.